Organon & Co.
Last updated September 27, 2026
Organization details
- Legal name
- Organon & Co.
- Ownership
- Public
- Status
- Active
- SIC code
- 2834 — Pharmaceutical Preparations
- Headquarters city
- Jersey City
- Headquarters state / province
- New Jersey
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- OGN
- Primary stock exchange
- NYSE
Identifiers
- SEC CIK
- 0001821825
- EIN
- 46-4838035
Board of directors
-
Alan Ezekowitz · DirectorSince 2023
-
Carrie Smith Cox · Director · Executive ChairSince 2023
-
Cynthia M. Patton · DirectorSince 2023
-
Deborah R. Leone · DirectorSince 2023
-
Grace Puma Whiteford · DirectorSince 2023
-
Helene D. Gayle · DirectorSince 2023
-
Kevin Ali · Director · Chief Executive OfficerSince 2023
-
Ma. Fatima Francisco · DirectorSince 2023
-
Martha E. McGarry · DirectorSince 2023
-
Philip Ozuah · DirectorSince 2023
-
Ramona Sequeira · DirectorSince 2025
-
Robert Essner · DirectorSince 2023
-
Rochelle B. Lazarus · DirectorSince 2023
-
Shalini Sharp · DirectorSince 2023
Chief executives
Kevin Ali
· Chief Executive Officer
Dates unknown
Director election results
Annual meeting of June 9, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
95.4%
-
95.9%
-
96.8%
-
96.9%
-
97.1%
-
97.1%
-
97.2%
-
97.2%
-
97.6%
Board connections
10 of this board's directors also sit on 17 other boards.
- via Alan Ezekowitz and Shalini Sharp
- via Shalini Sharp
- via Rochelle B. Lazarus
- via Carrie Smith Cox
- via Deborah R. Leone
- via Ramona Sequeira
- via Ma. Fatima Francisco
- via Alan Ezekowitz
- via Ma. Fatima Francisco
- via Shalini Sharp
- via Helene D. Gayle
- via Grace Puma Whiteford
- via Carrie Smith Cox
- via Grace Puma Whiteford
- via Carrie Smith Cox
- via Philip Ozuah
- via Helene D. Gayle
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $854,704
- 2 purchases by 2 insiders
- Sold, last 12 months
- $200,307
- 1 sale by 1 insider
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 11, 2026 | Arjona Ferreira Juan Camilo Officer (Head of R&D & CMO) | Option exercise | +11,519 | — | — |
| Aug 11, 2026 | Arjona Ferreira Juan Camilo Officer (Head of R&D & CMO) | Shares withheld for tax | −4,134 | $13.62 | $56,305 |
| Aug 5, 2026 | Drinane Juliana Papa Officer (Head of Mfg & Supply) | Open-market sale | −14,761 | $13.57 | $200,307 |
| May 6, 2026 | Holzbaur Lynette Officer (SVP and Corporate Controller) | Open-market purchase | +26,448 | $13.35 | $353,086 |
| Mar 31, 2026 | Drinane Juliana Papa Officer (Interim Head of Mfg & Supply) | Option exercise | +6,378 | — | — |
| Mar 31, 2026 | Arjona Ferreira Juan Camilo Officer (Head of R&D & CMO) | Option exercise | +13,431 | — | — |
| Mar 31, 2026 | Karp Daniel Officer (Executive VP, Corp. Dev.) | Option exercise | +11,338 | — | — |
| Mar 31, 2026 | Stahler Rachel A Officer (Chief Information Officer) | Option exercise | +6,555 | — | — |
| Mar 31, 2026 | Matthew M. Walsh Officer (Chief Financial Officer) | Option exercise | +12,047 | — | — |
| Mar 31, 2026 | Falcione Aaron Officer (Chief Human Resources Officer) | Option exercise | +6,732 | — | — |
| Mar 31, 2026 | Weaver Kirke Officer (Gen. Counsel & Corp. Secy.) | Option exercise | +6,201 | — | — |
| Mar 31, 2026 | Nisita Vittorio Officer (Head of Global Business Svcs) | Option exercise | +4,606 | — | — |
| Mar 31, 2026 | Holzbaur Lynette Officer (SVP and Corporate Controller) | Option exercise | +4,252 | — | — |
| Mar 31, 2026 | Morrissey Joseph T. Jr. Officer (Interim CEO) | Option exercise | +7,795 | — | — |
| Mar 31, 2026 | Drinane Juliana Papa Officer (Interim Head of Mfg & Supply) | Shares withheld for tax | −2,185 | $5.70 | $12,455 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.